Home / Netherlands / Kiadis Pharma N.V.
Kiadis Pharma N.V.
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
12 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
October 15, 2018 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| February 26, 2020 | Voleon Capital Management LP | 0.28% | still open |
| February 25, 2020 | Voleon Capital Management LP | 0.59% | still open |
| February 20, 2020 | Voleon Capital Management LP | 0.68% | still open |
| February 17, 2020 | Voleon Capital Management LP | 0.79% | still open |
| January 28, 2020 | Voleon Capital Management LP | 0.80% | still open |
| January 20, 2020 | Voleon Capital Management LP | 0.71% | still open |
| December 11, 2019 | Voleon Capital Management LP | 0.60% | still open |
| December 3, 2019 | Voleon Capital Management LP | 0.59% | still open |
| November 26, 2019 | Voleon Capital Management LP | 0.63% | still open |
| November 21, 2019 | Voleon Capital Management LP | 0.51% | still open |
| October 24, 2018 | GSA Capital Partners LLP | 0.42% | still open |
| October 15, 2018 | GSA Capital Partners LLP | 0.51% | still open |
Other companies sold short in the Netherlands
- Signify N.V. 10.08% of the capital sold short
- Akzo Nobel N.V. 8.44% of the capital sold short
- Pharming Group N.V. 8.11% of the capital sold short
- The Magnum Ice Cream Company N.V. 6.43% of the capital sold short
- Imcd N.V. 5.61% of the capital sold short
- Basic-Fit N.V. 4.23% of the capital sold short
- Fugro N.V. 4.13% of the capital sold short
- DSM-Firmenich AG 3.65% of the capital sold short
- PostNL N.V. 3.07% of the capital sold short
- Alfen N.V. 2.27% of the capital sold short
- Shell plc 2.05% of the capital sold short
- Arcadis N.V. 1.76% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Kiadis Pharma N.V., source AFM, data as at February 26, 2020, https://www.quivad.com/action/kiadis-pharma-n-v